Slide Insurance director sells 10,000 shares

Slide Insurance Holdings director Stephen L. Rohde reported multiple transactions in company securities.

Rhea-AI Filing Summary

Slide Insurance Holdings director Stephen L. Rohde reported multiple transactions in company securities. On March 3 and 4, he exercised stock options to acquire a total of 10,000 shares of common stock through derivative exercises at exercise prices reflecting a 5.5‑to‑1 forward stock split, with the options described as fully vested and exercisable. He then sold 5,000 shares at $19.16 per share on March 3 and 5,000 shares at $19.50 per share on March 4 in open-market transactions. Following these trades, his reported direct common stock holdings were reduced to zero, while 17,500 stock options remained outstanding directly owned.

Insider Trade Summary

Exercise and Sale: 10,000 shares ($193K approx. pre-tax spread)

Exercise and Sale 6 txns

Insider ROHDE STEPHEN L

Role Director

Sold 10,000 shs ($193K)

Approx. gross sale proceeds $193K

Approx. exercise cost $18.00

Approx. pre-tax spread $193K

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy)	5,000	$0.00	$0.00
Exercise	Common Stock	5,000	$0.0018	$9.00
Sale	Common Stock	5,000	$19.50	$98K
Exercise	Stock Option (Right to Buy)	5,000	$0.00	$0.00
Exercise	Common Stock	5,000	$0.0018	$9.00
Sale	Common Stock	5,000	$19.16	$96K

Holdings After Transaction: Stock Option (Right to Buy) — 17,500 contracts (Direct); Common Stock — 0 shares (Direct)

Footnotes (2)

1. F1. The exercise price gives effect to the 5.5-to-1 forward stock split that occured as part of the Issuer's initial public offering.
2. F2. These stock options are fully vested and exercisable.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Slide Insurance (SLDE) director Stephen L. Rohde report?

Stephen L. Rohde reported exercising stock options to acquire 10,000 Slide Insurance common shares, then selling 5,000 shares at $19.16 and 5,000 shares at $19.50. These were open‑market sales following derivative exercises of fully vested options.

How many Slide Insurance (SLDE) shares did the director sell and at what prices?

The director sold a total of 10,000 Slide Insurance common shares. He sold 5,000 shares at $19.16 per share on March 3 and 5,000 shares at $19.50 per share on March 4 in open‑market or private transactions.

Did the Slide Insurance (SLDE) director acquire shares through option exercises?

Yes. On March 3 and 4, the director exercised stock options to acquire 10,000 Slide Insurance common shares. The options were fully vested and exercisable, and their exercise prices give effect to a 5.5‑to‑1 forward stock split tied to the company’s initial public offering.

What is Stephen L. Rohde’s Slide Insurance (SLDE) common stock position after these Form 4 trades?

After the reported March 3–4 sales, the director’s reported direct common stock holdings were zero. However, he continued to hold 17,500 stock options directly, which are fully vested and exercisable according to the disclosure footnotes.

How many Slide Insurance (SLDE) stock options does the director still hold after the transactions?

Following the March 3 and March 4 option exercises and related share sales, the director reported directly holding 17,500 stock options. The filing notes these options are fully vested and exercisable, and their exercise price reflects a 5.5‑to‑1 forward stock split.

What does the 5.5-to-1 forward stock split note mean for Slide Insurance (SLDE) options?

The footnote explains that the reported exercise price for the director’s options incorporates a 5.5‑to‑1 forward stock split completed as part of Slide Insurance’s initial public offering. This means option terms, including exercise price, were adjusted to reflect that split.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/05/2026 - 07:17 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ROHDE STEPHEN L

(Last) (First) (Middle)

C/O SLIDE INSURANCE HOLDINGS, INC.

4221 W. BOY SCOUT BLVD., SUITE 200

(Street)

TAMPA FL 33607

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Slide Insurance Holdings, Inc. [ SLDE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/03/2026		M		5,000	A	$0.0018(1)	5,000	D
Common Stock	03/03/2026		S		5,000	D	$19.16	0	D
Common Stock	03/04/2026		M		5,000	A	$0.0018(1)	5,000	D
Common Stock	03/04/2026		S		5,000	D	$19.5	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$0.0018(1)	03/03/2026		M			5,000	(2)	10/07/2031	Common Stock	5,000	$0	22,500	D
Stock Option (Right to Buy)	$0.0018(1)	03/04/2026		M			5,000	(2)	10/07/2031	Common Stock	5,000	$0	17,500	D

Explanation of Responses:

1. The exercise price gives effect to the 5.5-to-1 forward stock split that occured as part of the Issuer's initial public offering.

2. These stock options are fully vested and exercisable.

	/s/ Stephen Rohde	03/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.